We have taken the decision to cancel this meeting.
Please accept our apologies for any inconvenience or disappointment this will cause. Please register your interest here if you would like updates on the meeting or topic.
The Transcription Factor-Directed Therapies Summit is the first in-person, industry-led conference in the field of precision molecular oncology, and it comes at a critical time for the profession.
Join the leading genomics, proteomics and translational science specialists in Transcription Factors and Targeted Protein Degradation to examine the latest challenges faced in drugging these notoriously undruggable targets, whilst harnessing novel discovery and screening technologies that are streamlining drug development and opening the field up to new therapeutics possibilities.
This unique discussion forum will equip you with the knowledge to utilize transcription factors as biomarkers to better predict disease prognosis and progression.
Ensure your Transcription Factor program reaches full clinical potential by gaining a better understanding of the underpinning biology of the transcription regulation network and how it relates to treating disease.
Don’t miss your chance to join leaders in Transcription Factor therapies development from Novartis, BMS, Scorpion Therapeutics, Ikena Oncology, Kronos Bio, Talus Bio and more!